Initial Temporal Muscle Thickness and Area: Poor Predictors of Neurological Outcome in Aneurysmal Subarachnoid Hemorrhage in a Central European Patient Cohort.

The temporalis muscle area (TMA) has been proclaimed as a surrogate parameter for estimating skeletal muscle mass. Pilot studies in Asian populations suggested temporal muscle thickness (TMT) and TMA as prognostic factors for neurological outcomes in aneurysmal subarachnoid hemorrhage (aSAH) patients. This study aimed to validate these findings in a larger European patient cohort. We retrospectively analyzed age, sex, aneurysm location, treatment, World Federation of Neurosurgical Societies (WFNS) grade, Fisher score, and modified Rankin Score (mRS) at six months in patients with aSAH. TMT and TMA measurements were obtained from initial native CT scans. Logistic regression with the dichotomized six-month mRS as the outcome incorporating TMT, weighted average of TMT, or TMA as predictors was performed. Of the included 478 patients, 66% were female, the mean age was 56, and 48% of patients had an mRS of three to six after six months. The mean TMT at the level of the Sylvian fissure was 5.9 (±1.7) mm in males and 4.8 (±1.8) mm in females. The mean TMA was 234.5 (±107.9) mm2 in females and 380 (±134.1) mm2 in males. WFNS grade (p < 0.001), Fisher score (p < 0.001), and age (p < 0.05) correlated significantly with the mRS after six months. No correlation was found between mRS after six months and the TMT at the Sylvian fissure (p = 0.3), the weighted average of TMT (p = 0.1), or the TMA (p = 0.1). In this central European patient cohort of 478 individuals, no significant associations were found between TMT/TMA and neurological outcomes following aSAH. Further prospective studies in diverse patient populations are necessary to determine the prognostic value of TMA and TMT in aSAH patients.

[1]  R. Helbok,et al.  The Loss of Temporal Muscle Volume is Associated with Poor Outcome in Patients with Subarachnoid Hemorrhage: An Observational Cohort Study , 2023, Neurocritical Care.

[2]  C. Rubbert,et al.  Evaluation of MTT Heterogeneity of Perfusion CT Imaging in the Early Brain Injury Phase: An Insight into aSAH Pathopysiology , 2023, Brain sciences.

[3]  C. Rubbert,et al.  Blood Pressure Affects the Early CT Perfusion Imaging in Patients with aSAH Reflecting Early Disturbed Autoregulation , 2023, Neurocritical Care.

[4]  K. Murotani,et al.  Predictive Value of Temporal Muscle Thickness for Sarcopenia after Acute Stroke in Older Patients , 2022, Nutrients.

[5]  D. Cantré,et al.  Significance of Temporal Muscle Thickness in Chronic Subdural Hematoma , 2022, Journal of clinical medicine.

[6]  S. Yang,et al.  Association between Temporal Muscle Thickness and Overall Survival in Non-Small Cell Lung Cancer Patients with Brain Metastasis , 2022, Current oncology.

[7]  Yu-Xuan Li,et al.  Long-term prognostic significance of sarcopenia in acute ischemic stroke , 2022, Medicine.

[8]  B. Roozenbeek,et al.  Early predictors of functional outcome in poor-grade aneurysmal subarachnoid hemorrhage: a systematic review and meta-analysis , 2022, BMC Neurology.

[9]  D. Nieboer,et al.  Development and Internal Validation of the ARISE Prediction Models for Rebleeding After Aneurysmal Subarachnoid Hemorrhage , 2022, Neurosurgery.

[10]  D. Eekers,et al.  Temporal muscle thickness as an independent prognostic imaging marker in newly diagnosed glioblastoma patients: A validation study , 2022, Neuro-oncology advances.

[11]  A. Viddeleer,et al.  Skeletal muscle atrophy and myosteatosis are not related to long-term aneurysmal subarachnoid hemorrhage outcome , 2022, PloS one.

[12]  J. Meixensberger,et al.  Newly Diagnosed IDH-Wildtype Glioblastoma and Temporal Muscle Thickness: A Multicenter Analysis , 2021, Cancers.

[13]  R. Stupp,et al.  Temporal Muscle Thickness as a Prognostic Marker in Patients with Newly Diagnosed Glioblastoma: Translational Imaging Analysis of the CENTRIC EORTC 26071–22072 and CORE Trials , 2021, Clinical Cancer Research.

[14]  J. H. Kim,et al.  Temporalis muscle thickness as an indicator of sarcopenia predicts progression-free survival in head and neck squamous cell carcinoma , 2021, Scientific Reports.

[15]  V. Y. Ng,et al.  Relevance of presenting risks of frailty, sarcopaenia and osteopaenia to outcomes from aneurysmal subarachnoid haemorrhage , 2021, BMC Geriatrics.

[16]  C. Rubbert,et al.  MTT Heterogeneity in Perfusion CT Imaging as a Predictor of Outcome after Aneurysmal SAH , 2021, American Journal of Neuroradiology.

[17]  Y. Kakizawa,et al.  Temporal muscle thickness and area are an independent prognostic factors in patients aged 75 or younger with aneurysmal subarachnoid hemorrhage treated by clipping , 2021, Surgical neurology international.

[18]  N. Rabelo,et al.  Sarcopenia as a Predictor of the Functional Outcome in Patients with Intracranial Aneurysms , 2022, Gerontology.

[19]  G. Langs,et al.  Evaluation of the Temporal Muscle Thickness as an Independent Prognostic Biomarker in Patients with Primary Central Nervous System Lymphoma , 2021, Cancers.

[20]  M. Nozoe,et al.  Reliability and validity of measuring temporal muscle thickness as the evaluation of sarcopenia risk and the relationship with functional outcome in older patients with acute stroke , 2021, Clinical Neurology and Neurosurgery.

[21]  Jae-Sung Park,et al.  Association between temporal muscle thickness and clinical outcomes in patients with newly diagnosed glioblastoma , 2020, Journal of Cancer Research and Clinical Oncology.

[22]  D. Prayer,et al.  Sarcopenia in Neurological Patients: Standard Values for Temporal Muscle Thickness and Muscle Strength Evaluation , 2020, Journal of clinical medicine.

[23]  T. Tominaga,et al.  Temporal Muscle as an Indicator of Sarcopenia is Independently Associated with Hunt and Kosnik Grade on Admission and the Modified Rankin Scale at 6 Month of Patients with Subarachnoid Hemorrhage Treated by Endovascular Coiling. , 2020, World neurosurgery.

[24]  Y. Kakizawa,et al.  Clinical characteristics of aneurysmal subarachnoid hemorrhage in the elderly over 75; would temporal muscle be a potential prognostic factor as an indicator of sarcopenia? , 2019, Clinical Neurology and Neurosurgery.

[25]  A. Molyneux,et al.  Prediction of Outcome After Aneurysmal Subarachnoid Hemorrhage: Development and Validation of the SAFIRE Grading Scale , 2019, Stroke.

[26]  H. Steiger,et al.  An introduction to the pathophysiology of aneurysmal subarachnoid hemorrhage , 2018, Neurosurgical Review.

[27]  René Rizzoli,et al.  Sarcopenia: revised European consensus on definition and diagnosis , 2018, Age and ageing.

[28]  D. Prayer,et al.  Temporal muscle thickness is an independent prognostic marker in melanoma patients with newly diagnosed brain metastases , 2018, Journal of Neuro-Oncology.

[29]  Hester F. Lingsma,et al.  Development and validation of outcome prediction models for aneurysmal subarachnoid haemorrhage: the SAHIT multinational cohort study , 2018, British Medical Journal.

[30]  J. Caspers,et al.  Timing of Mean Transit Time Maximization is Associated with Neurological Outcome After Subarachnoid Hemorrhage , 2017, Clinical Neuroradiology.

[31]  H. Steiger,et al.  Early Perfusion Computerized Tomography Imaging as a Radiographic Surrogate for Delayed Cerebral Ischemia and Functional Outcome After Subarachnoid Hemorrhage , 2013, Stroke.

[32]  David Hasan,et al.  Clinical Prediction Models for Aneurysmal Subarachnoid Hemorrhage: A Systematic Review , 2013, Neurocritical Care.

[33]  A. Algra,et al.  Long-term outcomes of patients with aneurysmal subarachnoid haemorrhage , 2011, The Lancet Neurology.

[34]  Ale Algra,et al.  Changes in case fatality of aneurysmal subarachnoid haemorrhage over time, according to age, sex, and region: a meta-analysis , 2009, The Lancet Neurology.

[35]  B. Stegmayr,et al.  Declining Mortality From Subarachnoid Hemorrhage: Changes in Incidence and Case Fatality From 1985 Through 2000 , 2004, Stroke.

[36]  V. Feigin,et al.  Stroke epidemiology: a review of population-based studies of incidence, prevalence, and case-fatality in the late 20th century , 2003, The Lancet Neurology.

[37]  K. Ranganathan,et al.  Temporalis muscle morphomics: the psoas of the craniofacial skeleton. , 2014, The Journal of surgical research.